MPX Relative Valuation
MPX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MPX is overvalued; if below, it's undervalued.
Historical Valuation

No Data
Competitors Valuation Multiple
The average P/S ratio for MPX's competitors is 1.03, providing a benchmark for relative valuation. Marine Products Corp Corp (MPX) exhibits a P/S ratio of 1.28, which is 25.08% above the industry average. Given its robust revenue growth of -14.91%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

PBPB
Potbelly Corp
10.220
USD
+0.39%

MVIS
MicroVision Inc
1.135
USD
-1.30%

XOMA
XOMA Corp
25.150
USD
-8.48%

GOCO
Gohealth Inc
6.700
USD
+3.16%

COFS
ChoiceOne Financial Services Inc
30.535
USD
+0.08%

TATT
TAT Technologies Ltd
32.100
USD
-7.81%

TTSH
Tile Shop Holdings Inc
5.915
USD
-1.25%

LFVN
LifeVantage Corp
13.470
USD
+2.20%

TSHA
Taysha Gene Therapies Inc
2.850
USD
+2.15%

PDLB
Ponce Financial Group Inc
13.880
USD
+1.02%
FAQ

Is Marine Products Corp (MPX) currently overvalued or undervalued?
Marine Products Corp (MPX) is now in the Fair zone, suggesting that its current forward PE ratio of 22.20 is considered Fairly compared with the five-year average of 16.32. The fair price of Marine Products Corp (MPX) is between 5.55 to 8.83 according to relative valuation methord.

What is Marine Products Corp (MPX) fair value?

How does MPX's valuation metrics compare to the industry average?

What is the current P/B ratio for Marine Products Corp (MPX) as of May 20 2025?

What is the current FCF Yield for Marine Products Corp (MPX) as of May 20 2025?

What is the current Forward P/E ratio for Marine Products Corp (MPX) as of May 20 2025?
